The Relationship Between Lycopene and Metabolic Diseases
Nutrients · 2024
DOI: 10.3390/nu16213708 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Anna Kulawik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, 3 Rokietnicka St., 60-806 Poznań, Poland. Hauptthemen laut MEDLINE: Lycopene, Antioxidants, Diabetes Mellitus, Type 2, Metabolic Syndrome. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education.
Abstract (Originalsprache)
Background
Metabolic syndrome, obesity, and type 2 diabetes are closely related. They are characterized by chronic inflammation and oxidative stress. Obesity is the most important risk factor for metabolic syndrome and type 2 diabetes. Metabolic syndrome is characterized by insulin resistance and elevated blood glucose levels, among other conditions. These disorders contribute to the development of type 2 diabetes, which can exacerbate other metabolic problems.
Methods
Numerous studies indicate that diet and nutrients can have a major impact on preventing and treating these conditions. One such ingredient is lycopene. It is a naturally occurring carotenoid with a unique chemical structure. It exhibits strong antioxidant and anti-inflammatory properties due to its conjugated double bonds and its ability to neutralize reactive oxygen species. Its properties make lycopene indirectly affect many cellular processes. The article presents studies in animal models and humans on the activity of this carotenoid in metabolic problems.
Results
The findings suggest that lycopene’s antioxidant and anti-inflammatory activities make it a promising candidate for the prevention and treatment of metabolic syndrome, obesity, and type 2 diabetes.
Conclusions
This review underscores the potential of lycopene as a beneficial dietary supplement in improving metabolic health and reducing the risk of associated chronic diseases. The conditions described are population diseases, so research into compounds with properties such as lycopene is growing in popularity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, 3 Rokietnicka St., 60-806 Poznań, Poland.
- Phytopharm Klęka S.A., Klęka 1, 63-040 Nowe Miasto nad Wartą, Poland.
- Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Wojska Polskiego Str. 71b, 60-630 Poznań, Poland.
- Department of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.
- Department of Orthopedics and Traumatology, Independent Public Clinical Hospital No. 1, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
ORCID-Profile: Judyta Cielecka-Piontek, Przemysław Zalewski
Förderung
- Ministry of Science and Higher Education
Zitieren
APA
Kulawik, A., Cielecka-Piontek, J., Czerny, B., Kamiński, A., & Zalewski, P. (2024). The Relationship Between Lycopene and Metabolic Diseases. Nutrients. https://doi.org/10.3390/nu16213708
Vancouver
Kulawik A, Cielecka-Piontek J, Czerny B, Kamiński A, Zalewski P. The Relationship Between Lycopene and Metabolic Diseases. Nutrients. 2024. doi:10.3390/nu16213708
BibTeX
@article{Kulawik2024,
author = {Kulawik, Anna and Cielecka-Piontek, Judyta and Czerny, Bogusław and Kamiński, Adam and Zalewski, Przemysław},
title = {The Relationship Between Lycopene and Metabolic Diseases},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16213708}
}
EUVIMED